MTD · NYSE · STOCK
Mettler Toledo (MTD) Stock Analysis
$1,417.38
52W $1023.05 – $1525.17
56/100
$28.67B
31.9
1.23
Is MTD Bullish or Bearish?
Bullish.
Innellis AI committee rates Mettler Toledo (MTD) Buy with a composite score of 56/100
, based on 6 analysts with 50% agreement.
Last updated August 17, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +18.52 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -1.48 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — high leverage (debt-to-equity 81.23) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 1816.3% shows genuine earnings power backing the valuation — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- P/E of 31.5 is moderate-to-rich — Value
- Price-to-book of 1299.4x prices in significant intangible value — Value
- Debt-to-equity of 81.23 adds balance-sheet risk to the value case — Value
- MACD histogram negative -- bearish momentum — Technical
- Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
- High leverage (debt-to-equity 81.23) amplifies downside in a stress scenario — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 17, 2026
Overall Committee Score
56/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 72%
of 192 Healthcare peers
Value Analyst
neutral
45
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 1816.3% shows genuine earnings power backing the valuation
− P/E of 31.5 is moderate-to-rich
Growth Analyst
bullish
68
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ 5 consecutive earnings beats -- consistent execution
Technical Analyst
neutral
51
/ 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Risk Analyst
bearish
32
/ 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 81.23) amplifies downside in a stress scenario
Macro Analyst
bullish
80
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
bullish
62
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2963.04)
Investment Thesis Evolution
Committee score moved marginally from 56.5 to 56.5.
- Recommendation changed from Watch to Buy.
- New bearish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- Portfolio Manager: +1 bearish signal(s).
Comparing 2026-08-16 to 2026-08-17 (1 day apart).
Technical Analysis
RSI (14)
56.6
Neutral
MACD Histogram
-3.098
Bearish Momentum
Trend Direction
Uptrend
Weekly: Downtrend
Market Structure
Hh Hl
Support
$1360.33
Resistance
$1508.87
Bollinger %B
0.64
Inside Bands
Price vs Moving Averages
EMA 9
$1,421.92
Below
EMA 21
$1,387.96
Above
EMA 50
$1,324.25
Above
EMA 200
$1,288.98
Above
Fundamental Analysis
Valuation
18
Growth
74
Profitability
75
Financial Health
13
Cash Flow
70
Valuation
P/E Ratio
31.9×
P/B Ratio
—
PEG Ratio
2.57
Dividend Yield
0.00%
52W High
$1525.17
52W Low
$1023.05
Quality & Growth
ROE
—
ROA
2341.2%
Gross Margin
5929.6%
Operating Margin
2869.2%
Revenue Growth YoY
—
Debt / Equity
—
AI Fundamental Assessment
P/E ratio of 31.9 (rich relative to a 15-40x range); Price-to-book of 2226.7x; PEG ratio of 2.6 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -3677.4%; Return on assets of 23.4%; Net margin of 21.9%; Gross margin of 59.3%; Current ratio of 1.12 (tight short-term liquidity); Debt-to-equity of 164.70; Free cash flow per share is positive (42.94); Most recent quarter beat estimates by 5.2%; 5 consecutive earnings beats; EPS growth accelerating (-33.3% -> +28.6% QoQ); Average YoY EPS growth of 13.6%; Analyst estimates falling over recent quarters
Get the Full MTD Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →